|
Term
|
Section
|
|
Acquisition Proposal
|
7.8(b)
|
|
Affected Employees
|
6.6(b)
|
|
Agreement
|
Preamble
|
|
Alternative Commitment Letter(s)
|
7.13(d)
|
|
Alternative Financing
|
7.13(d)
|
|
Anti-Corruption Laws
|
3.17(d)(i)
|
|
Anti-Discrimination Laws
|
3.15(i)
|
|
Antitrust Laws
|
7.1(b)(ii)
|
|
Bank of America
|
4.15(a)
|
|
Book-Entry Shares
|
1.4(b)
|
|
Brokers and Finders Fees
|
3.24
|
|
Cancelled Shares
|
1.4(d)
|
|
Cap Amount
|
6.3(d)
|
|
Capital Budget
|
5.1(g)
|
|
CERCLA
|
3.18(b)
|
|
Certificate
|
1.4(b)
|
|
Certificate of Merger
|
1.1(b)
|
|
Change in Control
|
6.6(a)
|
|
Change in the Company Recommendation
|
5.2(a)
|
|
Chevron
|
Recitals
|
|
Chevron Agreement
|
Recitals
|
|
Chevron Termination Fee
|
Recitals
|
|
Citi
|
4.15(a)
|
|
Closing
|
1.1(d)
|
|
Closing Date
|
1.1(d)
|
|
Code
|
1.6(c)
|
|
Commitment Letters
|
4.15(a)
|
|
Committed Financing
|
4.15(a)
|
|
Common Shares Trust
|
2.2(b)
|
|
Company
|
Preamble
|
|
Company 10-K
|
3.7(a)
|
|
Company Balance Sheet
|
3.8
|
|
Company Balance Sheet Date
|
3.8
|
|
Company Benefit Plans
|
3.15(a)
|
|
Company By-Laws
|
3.1
|
|
Company Capital Stock
|
3.5
|
|
Company Charter
|
3.1
|
|
Company Common Stock
|
Recitals
|
|
Company Credit Agreement
|
5.1(l)
|
|
Company Deferred Stock Award
|
1.6(e)
|
|
Company Disclosure Schedules
|
III
|
|
Company Environmental Permits
|
3.18(a)
|
|
Company Intellectual Property
|
3.22(a)
|
|
Company Material Adverse Effect
|
3.1
|
|
Company Pension Plan
|
3.15(e)
|
|
Company Preferred Stock
|
3.5
|
|
Company Proxy Statement
|
3.9(a)
|
|
Company PU Award
|
1.6(c)
|
|
Company Recommendation
|
5.2(f)
|
A-iv
|
Term
|
Section
|
|
Company RS Award
|
1.6(d)
|
|
Company RSU Award
|
1.6(b)
|
|
Company SEC Documents
|
3.7(a)
|
|
Company Securities
|
3.5
|
|
Company Stock Option
|
1.6(a)
|
|
Company Stockholder Approval
|
3.2(a)
|
|
Company Stockholder Meeting
|
5.2(f)
|
|
Company Subsidiary Securities
|
3.6(b)
|
|
Confidentiality Agreement
|
7.3
|
|
Contract
|
3.21(a)
|
|
Creditors’ Rights
|
3.2(a)
|
|
De Minimis Inaccuracies
|
8.2(a)
|
|
Debt Commitment Letters
|
4.15(a)
|
|
Debt Fee Letters
|
4.15(a)
|
|
Delaware Court
|
10.8
|
|
DGCL
|
Recitals
|
|
Dissenting Share
|
1.5
|
|
Economic Sanctions/Trade Laws
|
3.17(d)(ii)
|
|
Effect
|
3.1
|
|
Effective Time
|
1.1(b)
|
|
End Date
|
9.1(b)(i)
|
|
Environmental Laws
|
3.18(b)
|
|
Equity Investment
|
4.15(c)
|
|
Equity Purchase Agreement
|
4.15(c)
|
|
ERISA
|
3.15(a)
|
|
ERISA Affiliate
|
3.15(d)
|
|
Excess Shares
|
2.2(a)
|
|
Exchange Act
|
3.3
|
|
Exchange Agent
|
2.1(a)
|
|
Exchange Ratio
|
1.4(a)
|
|
Exchange Ratio Reduction Number
|
1.4(f)
|
|
Exercise Price
|
1.6(a)
|
|
Financial Advisors
|
3.24
|
|
Financing
|
7.13(g)
|
|
Financing Sources
|
9.2
|
|
Foreign Company Benefit Plan
|
3.15(a)
|
|
Form S-4
|
4.8(a)
|
|
GAAP
|
3.8
|
|
Government Official
|
3.17(a)
|
|
Hazardous Substance
|
3.18(b)
|
|
HSR Act
|
3.3
|
|
Hydrocarbon Contract
|
3.20(a)
|
|
Hydrocarbons
|
3.20(a)
|
|
Indemnified Liabilities
|
6.3(a)
|
|
Indemnified Persons
|
6.3(a)
|
|
Intellectual Property
|
3.22(a)
|
|
Intervening Event
|
5.2(b)(ii)
|
|
Intervening Event Match Period
|
5.2(b)(ii)
|
|
Intervening Event Notice
|
5.2(b)(ii)
|
|
knowledge
|
3.10(e)
|
A-v
|
Term
|
Section
|
|
Lien
|
3.4
|
|
Material Contract
|
3.21(b)
|
|
Measurement Date
|
3.5
|
|
Merger
|
Recitals
|
|
Merger Consideration
|
1.4(a)
|
|
Merger Subsidiary
|
Preamble
|
|
MLP
|
3.6(a)
|
|
MLP 10-K
|
3.7(b)
|
|
MLP Balance Sheet
|
3.8
|
|
MLP Common Units
|
3.6(c)
|
|
MLP Partnership Agreement
|
3.6(c)
|
|
MLP Partnership Interests
|
3.6(c)
|
|
MLP SEC Documents
|
3.7(b)
|
|
MLP Securities
|
3.6(c)
|
|
Money Laundering Laws
|
3.17(d)(iii)
|
|
NYSE
|
1.4(f)
|
|
OFAC
|
3.17(d)(ii)
|
|
Operating Partnership
|
3.6(a)
|
|
Option Consideration
|
1.6(a)
|
|
Original Financing Failure
|
7.13(d)
|
|
Parent
|
Preamble
|
|
Parent 10-K
|
4.6(a)
|
|
Parent Balance Sheet
|
4.7
|
|
Parent Balance Sheet Date
|
4.7
|
|
Parent Closing Price
|
1.6(a)
|
|
Parent Common Stock
|
Recitals
|
|
Parent Common Stock Issuance
|
Recitals
|
|
Parent Disclosure Schedules
|
IV
|
|
Parent Material Adverse Effect
|
4.1
|
|
Parent Measurement Date
|
4.5
|
|
Parent Preferred Stock
|
4.5
|
|
Parent SEC Documents
|
4.6(a)
|
|
Parent Securities
|
4.5
|
|
Parent Stock/Cash Award
|
1.6(d)
|
|
Parent Stock/Cash Unit Award
|
1.6(b)
|
|
PATRIOT Act
|
7.13(g)
|
|
Payor
|
10.5(c)
|
|
Per Share Cash Amount
|
1.4(a)
|
|
Permitted Commitment Reductions
|
7.13(b)
|
|
Person
|
2.1(c)
|
|
Personal Data
|
3.22(b)
|
|
Privacy Policies
|
3.22(b)
|
|
Proceeding
|
6.3(a)
|
|
RCRA
|
3.18(b)
|
|
Recipient
|
10.5(c)
|
|
Release
|
3.18(b)
|
|
Sanctions Target
|
3.17(d)(iv)
|
|
Sarbanes-Oxley Act
|
3.10(a)
|
|
SEC
|
1.6(g)
|
|
Securities Act
|
3.3
|
A-vi
|
Term
|
Section
|
|
Share Cap
|
1.4(f)
|
|
Significant Subsidiaries
|
3.6(a)
|
|
Subsidiary
|
3.6(a)
|
|
Substantial Detriment
|
7.1(c)
|
|
Substitute Commitment Letter(s)
|
7.13(c)
|
|
Substitute Financing
|
7.13(c)
|
|
Superior Proposal
|
7.8(b)
|
|
Superior Proposal Match Period
|
5.2(b)(i)
|
|
Superior Proposal Notice
|
5.2(b)(i)
|
|
Surviving Corporation
|
1.1(a)
|
|
Tax Proceeding
|
3.14
|
|
Tax Returns
|
3.14
|
|
Taxes
|
3.14
|
|
Termination Fee
|
10.5(a)(ii)
|
|
Transaction Litigation
|
7.14
|
|
Transaction Uses
|
4.15(g)
|
|
Transactions
|
Recitals
|
|
WES GP
|
3.6(a)
|
|
WES GP Interest
|
3.6(c)
|
A-vii
